Sleep Number - SNBR Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sleep Number in the last year. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNBR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNBR, but not buy additional shares or sell existing shares.
View SNBR analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued twelve-month price targets for Sleep Number's stock. Their SNBR share price forecasts range from $26.00 to $45.00. On average, they expect the company's share price to reach $34.00 in the next twelve months. This suggests a possible upside of 13.1% from the stock's current price.
View analysts price targets for SNBR or view top-rated stocks among Wall Street analysts.

Sleep Number's stock was trading at $76.60 at the beginning of the year. Since then, SNBR shares have decreased by 60.8% and is now trading at $30.05.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our SNBR earnings forecast.

Sleep Number Co. (NASDAQ:SNBR) announced its quarterly earnings results on Wednesday, October, 26th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.16. The business earned $540.57 million during the quarter, compared to analysts' expectations of $527.98 million. Sleep Number had a negative trailing twelve-month return on equity of 11.99% and a net margin of 2.52%.

Sleep Number updated its FY 2022 earnings guidance on Wednesday, November, 2nd. The company provided earnings per share (EPS) guidance of $1.50-$2.00 for the period, compared to the consensus estimate of $3.29. The company issued revenue guidance of -.

383 employees have rated Sleep Number Chief Executive Officer Shelly Ibach on Glassdoor.com. Shelly Ibach has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sleep Number investors own include AbbVie (ABBV), Intel (INTC), Micron Technology (MU), UnitedHealth Group (UNH), Alibaba Group (BABA), Netflix (NFLX), Advanced Micro Devices (AMD), Cisco Systems (CSCO), NVIDIA (NVDA) and Broadcom (AVGO).

Sleep Number trades on the NASDAQ under the ticker symbol "SNBR."

Sleep Number's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.55%), Vanguard Group Inc. (10.55%), Disciplined Growth Investors Inc. MN (9.71%), Thrivent Financial for Lutherans (3.50%), State Street Corp (3.35%) and Dimensional Fund Advisors LP (3.12%). Insiders that own company stock include Brenda J Lauderback, Christopher D Krusmark, Daniel Alegre, David R Callen, Deborah L Kilpatrick, Jean Michel Valette, Joseph Hunter Saklad, Kathleen L Nedorostek, Kevin Kennedy Brown, Melissa Barra, Michael J Harrison, Patricia Ann Dirks, Robert Joseph Poirier, Samuel R Hellfeld, Shelly Radue Ibach and Stephen L Gulis Jr.
View institutional ownership trends.

Shares of SNBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNBR stock can currently be purchased for approximately $30.05.

Sleep Number (NASDAQ:SNBR) has a market capitalization of $661.10 million and generates $2.18 billion in revenue each year. The company earns $153.75 million in net income (profit) each year or $2.32 on an earnings per share basis.

The company employs 5,515 workers across the globe.

Sleep Number's mailing address is 1001 THIRD AVENUE SOUTH, MINNEAPOLIS MN, 55404. The official website for the company is www.sleepnumber.com. The company can be reached via phone at (763) 551-7000, via email at investorrelations@sleepnumber.com, or via fax at 763-551-7123.